![Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial | American Society of Nephrology Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial | American Society of Nephrology](https://jasn.asnjournals.org/content/jnephrol/32/2/502/F1.large.jpg)
Steering Transplant Immunosuppression by Measuring Virus-Specific T Cell Levels: The Randomized, Controlled IVIST Trial | American Society of Nephrology
![Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41423-019-0306-1/MediaObjects/41423_2019_306_Fig1_HTML.png)
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment | Cellular & Molecular Immunology
![Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States | American Society of Nephrology Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/14/3/421/F1.large.jpg)
Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States | American Society of Nephrology
![Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2468024920316491-fx1.jpg)
Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation - ScienceDirect
![Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review | Journal of the American Heart Association Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/a9536326-7653-4cc1-bfad-8ad52e123fbf/jah36405-fig-0001.png)
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review | Journal of the American Heart Association
![The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b0a70aa9-cbb1-4169-bdab-d8d7e575f460/tri12553-fig-0001-m.jpg)
The need for minimization strategies: current problems of immunosuppression - Bamoulid - 2015 - Transplant International - Wiley Online Library
![Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano](https://pubs.acs.org/cms/10.1021/acsnano.0c10764/asset/images/large/nn0c10764_0001.jpeg)
Zoledronic Acid–Gadolinium Coordination Polymer Nanorods for Improved Tumor Radioimmunotherapy by Synergetically Inducing Immunogenic Cell Death and Reprogramming the Immunosuppressive Microenvironment | ACS Nano
![High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy | SpringerLink High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00262-016-1810-0/MediaObjects/262_2016_1810_Fig1_HTML.gif)
High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy | SpringerLink
![Severe and multifaceted systemic immunosuppression caused by experimental cancers of the central nervous system requires release of non-steroid soluble mediators | bioRxiv Severe and multifaceted systemic immunosuppression caused by experimental cancers of the central nervous system requires release of non-steroid soluble mediators | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/25/2020.03.24.006825/F7.large.jpg)
Severe and multifaceted systemic immunosuppression caused by experimental cancers of the central nervous system requires release of non-steroid soluble mediators | bioRxiv
![Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells: Molecular Therapy Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells: Molecular Therapy](https://www.cell.com/cms/attachment/b1d416d4-50fb-424e-b2fe-586a5c00fa77/fx1_lrg.jpg)
Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-κB signaling pathway in CD4 T cells: Molecular Therapy
![Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer | Journal for ImmunoTherapy of Cancer Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/6/e002356/F2.large.jpg)
Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer | Journal for ImmunoTherapy of Cancer
![IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines | PNAS IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines | PNAS](https://www.pnas.org/cms/10.1073/pnas.2120956119/asset/c04f4d2e-3653-443d-8bce-cc6429396e9a/assets/images/large/pnas.2120956119fig01.jpg)
IKKα-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines | PNAS
![Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias - ScienceDirect Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2405500X20303868-fx1.jpg)
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias - ScienceDirect
![Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International - Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -](https://onlinelibrary.wiley.com/cms/asset/f79c866f-64c6-4372-8a09-689a01ff8e87/tri13952-toc-0001-m.jpg)
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐making - Hellemans - 2021 - Transplant International -
![PDF) Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden PDF) Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden](https://www.researchgate.net/profile/Kazuaki-Takabe/publication/236045948/figure/fig5/AS:299345644670980@1448380971506/Reduction-of-overall-tumor-burden-by-primary-tumor-resection-reversed-the_Q320.jpg)
PDF) Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden
![Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022 - American Journal of Kidney Diseases Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022 - American Journal of Kidney Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3b0c6a08-95c4-4179-a417-052b81be92a8/gr1_lrg.jpg)
Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022 - American Journal of Kidney Diseases
![Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-022-01282-8/MediaObjects/13045_2022_1282_Fig1_HTML.png)
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets | Journal of Hematology & Oncology | Full Text
![Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567539421000943-ga1.jpg)
Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer - ScienceDirect
![PDF) High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored? PDF) High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?](https://i1.rgstatic.net/publication/257136347_High_immunosuppressive_burden_in_advanced_hepatocellular_carcinoma_patients_Can_effector_functions_be_restored/links/540efa8e0cf2d8daaad002a4/largepreview.png)